Last reviewed · How we verify
JLP-1310, Fasted followed by fed — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
JLP-1310, Fasted followed by fed (JLP-1310, Fasted followed by fed) — Jeil Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| JLP-1310, Fasted followed by fed TARGET | JLP-1310, Fasted followed by fed | Jeil Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- JLP-1310, Fasted followed by fed CI watch — RSS
- JLP-1310, Fasted followed by fed CI watch — Atom
- JLP-1310, Fasted followed by fed CI watch — JSON
- JLP-1310, Fasted followed by fed alone — RSS
Cite this brief
Drug Landscape (2026). JLP-1310, Fasted followed by fed — Competitive Intelligence Brief. https://druglandscape.com/ci/jlp-1310-fasted-followed-by-fed. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab